Type6 Therapeutics is a startup, 1 tracked investor.
Type6 Therapeutics is a startup. Brouky records 1 investor associated with the company.
Type6 Therapeutics applies computational biology to identify and develop therapies that target disease-driving kinases. The company focuses on kinase-targeted drug discovery using in silico approaches.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.